Belite Bio, Inc Income (Loss) from Continuing Operations before Income Taxes, Domestic
Belite Bio, Inc (BLTE) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$2.57 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-31
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$2.57M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$2.73M 20-F · filed 2026-03-31 |
| 2023-12-31 | -$1.79M 20-F · filed 2026-03-31 |
| 2022-12-31 | -$1.10M 20-F · filed 2025-03-17 |
| 2021-12-31 | -$413.00K 20-F · filed 2024-03-12 |
| 2020-12-31 | -$331.00K 20-F · filed 2023-03-31 |